1.	Phase II Diagnostic Study of Intraoperative Lymph Node Mapping for Primary Breast Cancer Using Technetium Tc 99m Sulfur Colloid and Isosulfan Blue (Summary Last Modified 01/98) Phase: Phase II Type: Diagnostic Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: RPCI-DS-95-14, NCI-G97-1333
2.	Axillary Reverse Mapping Phase: Phase II Type: Diagnostic Status: Closed Age: 18 to 100 Sponsor: Other Protocol IDs: 11737, NCT01381315
3.	Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer Phase: Phase I Type: Diagnostic Status: Completed Age: Over 21 Sponsor: Other Protocol IDs: 2007P-000431, NCT00721370
4.	Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-11785, NCI-G00-1780, MCC-IRB-5033, NCT00005640
5.	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 to 70 Sponsor: NCI, Other Protocol IDs: CDR0000068489, NYU-9917, NCI-G01-1915, NCT00012168
6.	Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069485, ACOSOG-Z0360, NCT00042926
7.	Randomized Study of Peritumoral Versus Periareolar Injection of Patent Blue V Dye and Technetium Tc 99m Sulfur Colloid in Patients With Stage I or II Breast Cancer Undergoing Sentinel Lymph Node Identification. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Diagnostic Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: STRAUSS-FRANSENOD, EU-20214, NCT00052676
8.	Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000331918, GOG-0206, NCT00070317
9.	Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer Phase: No phase specified Type: Diagnostic Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: ID01-538, P30CA016672, MDA-ID-01538, CDR0000355838, NCT00438477
10.	Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000378197, U10CA031946, CALGB-140203, NCT00089310
11.	Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: 02-127, NCT00595725
12.	Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000611987, P30CA015083, MC0734, 07-008292, MAYO-MC0734, MAYO-07-008292, NCT00743314
13.	Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EPROST-20040015, SCCC-2003161, WIRB-20050911, SCCC-20050911, SCCC-20040015, NCT00450723
14.	Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CC085513, H46038-33934, NCT01008969